Staphylococcal enterotoxin A–activated regulatory T cells promote allergen-specific TH2 response to intratracheal allergen inoculation  Wei-ping Zeng,

Slides:



Advertisements
Similar presentations
Exposure to allergen and diesel exhaust particles potentiates secondary allergen- specific memory responses, promoting asthma susceptibility  Eric B. Brandt,
Advertisements

Cell-to-cell contact between activated CD4+ T lymphocytes and unprimed monocytes interferes with a TH1 response  Miriam Wittmann, MD, Mareike Alter, Tanja.
CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation  Jae-Won Oh, MD, PhD, Christine M. Seroogy,
The activating protein 1 transcription factor basic leucine zipper transcription factor, ATF- like (BATF), regulates lymphocyte- and mast cell–driven immune.
Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model  Sylvie Amu, PhD, Sean P.
The activating protein 1 transcription factor basic leucine zipper transcription factor, ATF- like (BATF), regulates lymphocyte- and mast cell–driven immune.
IL-25 and CD4+ TH2 cells enhance type 2 innate lymphoid cell–derived IL-13 production, which promotes IgE-mediated experimental food allergy  Jee-Boong.
Volume 136, Issue 4, Pages e3 (April 2009)
Selective control of SIRP-α–positive airway dendritic cell trafficking through CD47 is critical for the development of TH2-mediated allergic inflammation 
Frank Kirstein, PhD, Natalie E
Lack of autophagy induces steroid-resistant airway inflammation
Protective role of nuclear factor of activated T cells 2 in CD8+ long-lived memory T cells in an allergy model  Roman Karwot, PhD, Joachim H. Maxeiner,
Insulin-like growth factor 2 enhances regulatory T-cell functions and suppresses food allergy in an experimental model  Gui Yang, MD, Xiao-Rui Geng, MD,
Exposure to allergen and diesel exhaust particles potentiates secondary allergen- specific memory responses, promoting asthma susceptibility  Eric B. Brandt,
T-cell regulation during viral and nonviral asthma exacerbations
Pentraxin 3 deletion aggravates allergic inflammation through a TH17-dominant phenotype and enhanced CD4 T-cell survival  Jyoti Balhara, MSc, Lianyu Shan,
Compartmentalized chemokine-dependent regulatory T-cell inhibition of allergic pulmonary inflammation  Roshi Afshar, PhD, James P. Strassner, BS, Edward.
IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs  Chien-Chang Chen, PhD, Takao Kobayashi, PhD, Koji Iijima,
Restoration of T-box–containing protein expressed in T cells protects against allergen- induced asthma  Jung Won Park, MD, Hyun Jung Min, MS, Jung Ho Sohn,
Antigen-specific effector CD8 T cells regulate allergic responses via IFN-γ and dendritic cell function  Yafang Tang, BSc, Shou Ping Guan, BSc, Benson.
Β-Glucan exacerbates allergic asthma independent of fungal sensitization and promotes steroid-resistant TH2/TH17 responses  Zhonghua Zhang, MD, Jocelyn.
Eosinophils contribute to the resolution of lung-allergic responses following repeated allergen challenge  Katsuyuki Takeda, MD, PhD, Yoshiki Shiraishi,
Lung dendritic cells induce TH17 cells that produce TH2 cytokines, express GATA-3, and promote airway inflammation  Marianne Raymond, PhD, Vu Quang Van,
Jun-Qi Yang, PhD, Khalid W
Signaling through FcRγ-associated receptors on dendritic cells drives IL-33–dependent TH2-type responses  Melissa Y. Tjota, BA, Cara L. Hrusch, PhD, Kelly.
Activin A and TGF-β promote TH9 cell–mediated pulmonary allergic pathology  Carla P. Jones, PhD, Lisa G. Gregory, PhD, Benjamin Causton, BSc, Gaynor A.
Surfactant protein D inhibits TNF-α production by macrophages and dendritic cells in mice  László Hortobágyi, MS, Sonja Kierstein, PhD, Kateryna Krytska,
Early-life chlamydial lung infection enhances allergic airways disease through age- dependent differences in immunopathology  Jay C. Horvat, PhD, Malcolm.
CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling  Jennifer Kearley, PhD, Douglas S. Robinson,
Volume 18, Issue 5, Pages (May 2003)
Frank Kirstein, PhD, Natalie E
Volume 140, Issue 7, Pages (June 2011)
Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3–positive regulatory versus TH2 effector cells to.
Innate responsiveness of CD8 memory T-cell populations nonspecifically inhibits allergic sensitization  Jamie A. Leggat, PhD, Deena L. Gibbons, PhD, Syeda.
T-cell immunoglobulin and mucin domain 1 deficiency eliminates airway hyperreactivity triggered by the recognition of airway cell death  Hye Young Kim,
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Bcl2-like protein 12 plays a critical role in development of airway allergy through inducing aberrant TH2 polarization  Zhi-Qiang Liu, MD, PhD, Ying Feng,
Takao Kobayashi, PhD, Koji Iijima, PhD, Alexander L
IL-2–inducible T-cell kinase modulates TH2-mediated allergic airway inflammation by suppressing IFN-γ in naive CD4+ T cells  Arun K. Kannan, MS, Nisebita.
Jethe O. F. Nunes, PhD, Juliana de Souza Apostolico, MSc, David A. G
Regulation of allergic airway inflammation by class I–restricted allergen presentation and CD8 T-cell infiltration  James W. Wells, PhD, Christopher J.
Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses  Shigeru Ashino, PhD, Katsuyuki Takeda, MD,
3-Methyl-4-nitrophenol triggers nasal allergy by modulating dendritic cell properties  Xiao-Yu Liu, PhD, Yong-Jin Wu, MD, PhD, Li-Juan Song, MD, Xian-Hai.
Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus–specific type 2 immune responses  Stephan Traidl, Petra Kienlin,
Chronic cat allergen exposure induces a TH2 cell–dependent IgG4 response related to low sensitization  Amedee Renand, PhD, Luis D. Archila, MSc, John.
Repressor of GATA regulates TH2-driven allergic airway inflammation and airway hyperresponsiveness  Kiyoshi Hirahara, MD, Masakatsu Yamashita, PhD, Chiaki.
A novel allergen-specific therapy with CD40-silenced B cells and dendritic cells  Motohiko Suzuki, MD, PhD, Makoto Yokota, MD, PhD, Yoshihisa Nakamura,
Role of B cells in TH cell responses in a mouse model of asthma
T-bet inhibits innate lymphoid cell–mediated eosinophilic airway inflammation by suppressing IL-9 production  Ayako Matsuki, MD, Hiroaki Takatori, MD,
Sarita Sehra, PhD, Weiguo Yao, PhD, Evelyn T. Nguyen, MS, Nicole L
T-bet inhibits innate lymphoid cell–mediated eosinophilic airway inflammation by suppressing IL-9 production  Ayako Matsuki, MD, Hiroaki Takatori, MD,
Fms-like tyrosine kinase 3 ligand increases a lung DC subset with regulatory properties in allergic airway inflammation  Zhifei Shao, MD, Arpita S. Bharadwaj,
Cell surface characterization of T lymphocytes and allergen-specific T cell clones: Correlation of CD26 expression with T H1 subsets  Martin Willheim,
Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3–positive regulatory T cells  Amir H. Massoud, MSc,
Direct ex vivo analysis of allergen-specific CD4+ T cells
Susceptibility to allergic lung disease regulated by recall responses of dual-receptor memory T cells∗  Mark A. Aronica, MD, Shadi Swaidani, MS, Yan H.
Enhanced production of CCL18 by tolerogenic dendritic cells is associated with inhibition of allergic airway reactivity  Iris Bellinghausen, PhD, Sebastian.
IL-10–treated dendritic cells decrease airway hyperresponsiveness and airway inflammation in mice  Toshiyuki Koya, MD, PhD, Hiroyuki Matsuda, MD, PhD,
Matthew J. Loza, PhD, Susan Foster, PhD, Stephen P
Duy Pham, PhD, Sarita Sehra, PhD, Xin Sun, PhD, Mark H. Kaplan, PhD 
DNA methylation of TH1/TH2 cytokine genes affects sensitization and progress of experimental asthma  Stephanie Brand, PhD, Dörthe Andrea Kesper, PhD,
IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation  Kentaro Takahashi, MD, Koichi.
Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production  Taylor A. Doherty, MD, Naseem Khorram,
MicroRNA-155 is essential for TH2-mediated allergen-induced eosinophilic inflammation in the lung  Carina Malmhäll, BSc, Sahar Alawieh, BSc, You Lu, PhD,
TH17 cells mediate pulmonary collateral priming
Eric B. Brandt, PhD, Melissa K. Mingler, MS, Michelle D
Ovalbumin-specific IgE modulates ovalbumin-specific T-cell response after repetitive oral antigen administration  Nemuko Omata, MD, Yusei Ohshima, MD,
Epicutaneous immunization with ovalbumin and CpG induces TH1/TH17 cytokines, which regulate IgE and IgG2a production  Monika Majewska-Szczepanik, PhD,
Corticosteroids enhance CD8+ T cell–mediated airway hyperresponsiveness and allergic inflammation by upregulating leukotriene B4 receptor 1  Hiroshi Ohnishi,
IL-2–inducible T-cell kinase modulates TH2-mediated allergic airway inflammation by suppressing IFN-γ in naive CD4+ T cells  Arun K. Kannan, MS, Nisebita.
Presentation transcript:

Staphylococcal enterotoxin A–activated regulatory T cells promote allergen-specific TH2 response to intratracheal allergen inoculation  Wei-ping Zeng, PhD, Margaret M. McFarland, MS, Baohua Zhou, PhD, Silva Holtfreter, Dr rer nat, Susan Flesher, MD, Ambrose Cheung, MD, Avishek Mallick, PhD  Journal of Allergy and Clinical Immunology  Volume 139, Issue 2, Pages 508-518.e4 (February 2017) DOI: 10.1016/j.jaci.2016.04.033 Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Regulation of TH differentiation of OVA-specific CD4 T cells by SEA. A, OVA-specific naive CD4 Tcon cells (CD4+CD62LhighKJ126+GFP−) from DO11.10.Foxp3.GFP mice were stimulated with APCs plus OVA323-339 peptide, IL-12, and SEA in the presence or absence of naive Treg cells (CD4+CD62LhighKJ126−GFP+) from BALB/c.Thy1.1.Foxp3.GFP mice. Cells were analyzed for cytokine expression on day 6 of culture. B, Experiments were set up as in Fig 1, A, except that naive antigen-nonspecific CD4 Tcon cells of BALB/c.Thy1.1.Foxp.GFP mice were used in the cocultures. After the differentiation culture, cells were stimulated with phorbol 12-myristate 13-acetate and ionomycin and analyzed for intracellular cytokine expression by using flow cytometry. Dot plots of IL-13 and IFN-γ expression in CD4+KJ126+GFP− cells of representatives of 3 experiments are shown. Numbers in dot plots are percentages of cells. Journal of Allergy and Clinical Immunology 2017 139, 508-518.e4DOI: (10.1016/j.jaci.2016.04.033) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 IL-4 expression by SEA-activated Treg cells. A, Naive Treg cells from BALB/c.Foxp3.GFP mice mixed with APCs or APCs alone were stimulated SEA in the presence of IL-12. On day 4, IL-4 in culture supernatants was measured by using ELISA. B, Ex vivo splenic cells of BALB/c.Foxp3.GFP mice were either unstimulated or stimulated with SEA in the presence of monensin for 6 hours. IL-4 expression was detected by means of intracellular cytokine staining. Dot plots of Treg cells (CD4+GFP+) are shown. C, BALB/c.Foxp3.GFP mice were intravenously injected with either PBS (−SEA) or 2 μg of SEA (+SEA). Six to 7 hours later, splenic cells were stained for cell-surface marker. Dot plots of CD69 and CD62L staining on gated Treg cells (CD4+GFP+) are shown. Numbers in dot plots indicate percentages of cells. Representatives of one of 2 experiments are shown. Journal of Allergy and Clinical Immunology 2017 139, 508-518.e4DOI: (10.1016/j.jaci.2016.04.033) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Analyses of asthmatic features of OVA-sensitized mice. A, BALB/c mice were intratracheally sensitized with OVA alone or together with SEA and intratracheally challenged with OVA or PBS, as indicated. On day 3 after the last challenge, BALF was collected from the mice. Total BALF cells and percentages of eosinophils and macrophages were determined. Averages and SDs of 3 mice per group of a representative of 3 experiments are shown. B, Histology of H&E-stained lung sections of mice in Fig 3, A. C, PAS staining of lung sections of mice sensitized with OVA or OVA plus SEA and challenged with OVA in Fig 3, A. D, Mice sensitized with OVA or OVA plus SEA were challenged with OVA as above. On day 3 after the last challenge, mice were subjected to bronchial challenge with increasing doses of methacholine. Pulmonary resistance at each dose of methacholine challenge was measured. Averages and SDs of 4 mice per group in 1 of 2 experiments are shown. Journal of Allergy and Clinical Immunology 2017 139, 508-518.e4DOI: (10.1016/j.jaci.2016.04.033) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 Effects of Treg cell transient depletion before sensitization with OVA plus SEA on asthma. A, Wild-type B6 mice or B6.Foxp3DTR mice (FDR) received 2 consecutive daily intraperitoneal injections of DT before the day of sensitization with OVA plus SEA. Mice were challenged with OVA as in Fig 3, A. Total cell numbers and percentages of eosinophils and macrophages in BALF were determined. Averages and SDs of 3 mice per group of a representative of 3 experiments are shown. B, Sections of lungs of the same mice as in Fig 4, A, were subject to H&E or PAS staining. C, Mice treated as in Fig 4, A, were subjected to bronchial methacholine challenge, and pulmonary resistance was measured. Averages and SDs of 4 mice per group in 1 of 2 experiments are shown. Journal of Allergy and Clinical Immunology 2017 139, 508-518.e4DOI: (10.1016/j.jaci.2016.04.033) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 5 Effects of SEA and Treg cell transient depletion on CDE-induced asthma. A, B6.Foxp3DTR mice were treated with or without 2 consecutive intraperitoneal injection of DT before intratracheal sensitization with CDE alone or plus SEA and challenged with CDE. Total cell numbers and percentages of eosinophils and macrophages in BALF were determined. Averages and SDs of 3 mice per group are shown. B, B6.Foxp3DTR mice sensitized with CDE alone or CDE plus SEA and challenged with CDE as in Fig 5, A, were subjected to bronchial challenge with increasing doses of methacholine. Pulmonary resistance was measured. Averages and SDs of 4 mice per group are shown. Asterisk indicates statistical significance of the difference as determined by the Student t test. Representatives of 2 experiments are shown. Journal of Allergy and Clinical Immunology 2017 139, 508-518.e4DOI: (10.1016/j.jaci.2016.04.033) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 6 Characterization of early T-cell response to allergen challenge. A, B6.Foxp3DTR mice (FDR) were treated with or without 2 consecutive daily intraperitoneal injections of DT before intratracheal sensitization with OVA and OVA323-339 peptide plus SEA and then intratracheally challenged once with OVA and OVA323-339 peptide for 8 to 9 hours. BALF cells were sequentially stained with phycoerythrin-labeled OVA-2C:IAb and OVA-3C:IAb tetramers and a cocktail of antibodies against surface markers. The cells were then fixed, permeabilized, and stained for IL-13 and IFN-γ. Middle panels are dot plots of CD4 and OVA tetramer staining gated on the TCRβ+ single T cells. Dot plots of IL-13 and IFN-γ staining of the CD4− (left) and CD4+ tetramer-positive (right) cells are shown. B, BALF cells of B6 mice sensitized and challenged with keyhole limpet hemocyanin (KLH) were stained with the OVA tetramers and CD4 as a negative control of tetramer staining. C, MLN cells of the same mice as in Fig 6, A, were treated and analyzed as in Fig 6, A. D, MLN cells of the same mice as in Fig 6, B, as negative controls of tetramer staining of MLN cells. Numbers in all plots are percentages of cell populations. Representatives of 3 experiments are shown. Journal of Allergy and Clinical Immunology 2017 139, 508-518.e4DOI: (10.1016/j.jaci.2016.04.033) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 7 Restoration of IL-13 expression by Treg cell reconstitution. B6.Foxp3DTR mice (FDR) were treated with 2 consecutive daily intraperitoneal injections of DT before intratracheal sensitization with OVA and OVA323-339 peptide plus SEA. On the day of the second DT injection, mice received either adoptive transfer of Treg cells derived from B6.Foxp3.GFP mice (FDR + DT + Treg) or PBS (FDR + DT). The mice were then sensitized and challenged, and BALF cells were analyzed as in Fig 5. Middle panels are dot plots of CD4 and OVA tetramer staining gated on the TCRβ+ T cells. Dot plots of IL-13 and IFN-γ staining of the CD4− (left) and CD4+ tetramer-positive (right) cells are shown. Numbers in all plots are percentages of the cell populations. Representatives of 2 experiments are shown. Journal of Allergy and Clinical Immunology 2017 139, 508-518.e4DOI: (10.1016/j.jaci.2016.04.033) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 In vitro TH differentiation of OVA specific CD4 Tcon cells in the absence of SEA. OVA-specific naive CD4 Tcon cells derived from DO11.10.Foxp3.GFP mice were mixed with or without antigen-nonspecific naive Treg cells derived from BALB/c.Thy1.1.Foxp3.GFP mice. Cells were stimulated with APC plus OVA323-339 peptide and IL-12. On day 6 of culture, cells were stimulated with phorbol 12-myristate 13-acetate and ionomycin. IFN-γ and IL-13 levels were measured based on intracellular cytokine staining. Dot plots of CD4+KJ126+GFP− populations are shown. Numbers are percentages of cells in each quadrant. Journal of Allergy and Clinical Immunology 2017 139, 508-518.e4DOI: (10.1016/j.jaci.2016.04.033) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E2 BALF cell differential staining. BALB/c mice were intratracheally sensitized with OVA or OVA plus SEA and challenged with either OVA or PBS, as indicated. BALF smear slides were stained with Diff-Quick solutions. Microscopic pictures of the stained slides are shown. Journal of Allergy and Clinical Immunology 2017 139, 508-518.e4DOI: (10.1016/j.jaci.2016.04.033) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E3 In vitro TH differentiation of OVA-specific CD4 Tcon cells of OTII.Foxp3.GFP mice. OVA-specific naive CD4 Tcon cells derived from OTII.Foxp3.GFP mice were mixed with or without antigen-nonspecific naive Treg cells derived from B6.Foxp3.GFP mice. Cells were stimulated with APC plus OVA323-339 peptide, SEA, and IL-12. On day 6 of culture, cells were stimulated with phorbol 12-myristate 13-acetate and ionomycin. IFN-γ and IL-13 levels were measured by means of intracellular cytokine staining. Dot plots of the OTII CD4 Tcon cells (CD4+TCRVβ5+) are shown. Numbers are percentages of cells in each quadrant. Journal of Allergy and Clinical Immunology 2017 139, 508-518.e4DOI: (10.1016/j.jaci.2016.04.033) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E4 Effects of Treg cell deletion after sensitization and before allergen challenge on asthma. B6.FoxpDTR mice were intratracheally sensitized with OVA or OVA plus SEA for 1 week. Before intratracheal challenge with OVA, mice were intraperitoneally injected with or without DT to deplete Treg cells. Mice were then intratracheally challenged 3 times with OVA. BALF from the mice were collected. Total numbers of cells and percentages of eosinophils, macrophages, and lymphocytes in BALF are shown. Journal of Allergy and Clinical Immunology 2017 139, 508-518.e4DOI: (10.1016/j.jaci.2016.04.033) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions